Unveiling a Multimodal Ayurvedic therapeutic strategy for Geriatric Mental Health: An Open-Label, Single-Arm Preliminary Prospective Trial of Brāhmī Ghṛta with Psychotherapeutic Guidance for Late-Life Depression
Brain Behavior and Immunity Integrative · 2026-11 · 100208
DOI: 10.1016/j.bbii.2026.100208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Behavior and Immunity Integrative, 2026-11. Verfasst von Sandeep S und 2 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Depression
Abstract (Originalsprache)
Introduction Mental health is a cumulative output of biological, social and environmental influences along with age related stressors. Globally 20% of adults aged 60 or more suffer from mental or neurological disorders. Cross-sectional studies in India have demonstrated an overall prevalence of late life psychiatric illness as 43% in which Late life Depression (LLD) constitutes significant morbidity and mortality along with high societal cost. This clinical study has focused on LLD and suitable correlations in Ayurveda aiding to develop a preliminary multidimensional protocol involving Pachana, Brāhmī Ghṛta , and Sattvāvajaya Cikitsā in improving clinical outcomes and quality of life. Methodology An exploratory single arm clinical trial, where 36 participants were recruited for the trial and administered with Pachana, Brāhmī Ghṛta , and Sattvāvajaya Cikitsā after diagnosis with DSM-5 criteria for a duration of 97 days with subsequent analysis. The clinical assessments were done on 0th day and 98th day with GDS-15 Scores and Quality of life analysis using PHQ-9 Questionnaire. Results and Discussion In the analysis of GDS-15, when nonparametric analysis was preferred due to baseline non-normality, the Wilcoxon signed-ranks test likewise showed a large change with a median paired difference of 4.5 points (SE 0.174), 95% CI 4.0–4.5, W = 666, p < 0.0001, and a very large standardized effect (d ≈ 1) whereas in PHQ-9, The difference of medians between baseline and post-treatment scores was 4.5 points (SE = 0.186), with a narrow 95% confidence interval ranging from 4.0 to 4.5. The Wilcoxon signed-rank test result (w = 666, p < 0.0001) indicates a highly reliable within-subject improvement among the 36 participants, despite minor deviations from normality (Effect size ~1). GDS 15. These findings have provided preliminary information on the effects of Brahmi and its nootropic efficiencies which might be through modulation of HPA axis and neurotransmitters, improving brain functions thereby eventually improving the mood. Integration of Sattvāvajaya Cikitsā might have regulated thought patterns and ensured moral support targeting the normalcy of Satva. Hence this trial has generated feasible precursory outcomes in the management of LLD by adopting a multidimensional approach rooted in Ayurveda.
Zitieren
APA
S, S., Soman, D., & K, S. (2026). Unveiling a Multimodal Ayurvedic therapeutic strategy for Geriatric Mental Health: An Open-Label, Single-Arm Preliminary Prospective Trial of Brāhmī Ghṛta with Psychotherapeutic Guidance for Late-Life Depression. Brain Behavior and Immunity Integrative, 100208. https://doi.org/10.1016/j.bbii.2026.100208
Vancouver
S S, Soman D, K S. Unveiling a Multimodal Ayurvedic therapeutic strategy for Geriatric Mental Health: An Open-Label, Single-Arm Preliminary Prospective Trial of Brāhmī Ghṛta with Psychotherapeutic Guidance for Late-Life Depression. Brain Behavior and Immunity Integrative. 2026:100208. doi:10.1016/j.bbii.2026.100208
BibTeX
@article{S2026,
author = {S, Sandeep and Soman, Devipriya and K, Sreejith},
title = {Unveiling a Multimodal Ayurvedic therapeutic strategy for Geriatric Mental Health: An Open-Label, Single-Arm Preliminary Prospective Trial of Brāhmī Ghṛta with Psychotherapeutic Guidance for Late-Life Depression},
journal = {Brain Behavior and Immunity Integrative},
year = {2026},
pages = {100208},
doi = {10.1016/j.bbii.2026.100208}
}
EUVIMED